A family of enzymes called caspases — best known for their involvement in programmed cell death — now seems to be pivotal in the progression of two neurodegenerative diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Galvan, V. et al. Proc. Natl Acad. Sci. USA 103, 7130–7135 (2006).
Graham, R. K. et al. Cell 125, 1179–1191 (2006).
Gervais, F. G. et al. Cell 97, 395–406 (2000).
Lu, D. C. et al. Nature Med. 6, 397–404 (2000).
Wellington, C. L. et al. J. Biol. Chem. 275, 19831–19838 (2000).
Hermel, E. et al. Cell Death Differ. 11, 424–438 (2004).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ellerby, L., Orr, H. Cut to the chase. Nature 442, 641–642 (2006). https://doi.org/10.1038/442641a
Published:
Issue Date:
DOI: https://doi.org/10.1038/442641a
